ARTICLE: Challenges in Pulmonary Hypertension: Controversies in Treating the Tip of the Iceberg

AUTHORS: Jason M Elinoff, Richa Agarwal, Christopher F Barnett, Raymond L Benza, Michael J Cuttica, Ahmed M. Gharib, Michael P Gray, Paul M Hassoun, Anna R Hemnes, Marc Humbert, Todd M Kolb, Tim Lahm, Jane A Leopold, Stephen C Mathai, Vallerie V McLaughlin, Ioana R Preston, Erika B Rosenzweig, Oksana A Shlobin, Virginia D Steen, Roham T Zamanian and Michael A. Solomon

JOURNAL: Am J Respir Crit Care Med. 2018 Feb 9. doi: 10.1164/rccm.201710-2093PP. [Epub ahead of print]

Abstract

The Critical Care Medicine Department of the National Institutes of Health Clinical Center and the Pulmonary Hypertension Association held a joint symposium to discuss "Challenges in Pulmonary Hypertension: Beating, Breathing, and Beyond." Communities of interest including patient advocates, clinicians, and academic investigators gathered together to raise awareness and highlight the challenges in diagnosing and treating pulmonary hypertension (PH). The current symposium focused on whether or not pulmonary arterial hypertension specific treatments are warranted as therapies for PH due to heart failure with preserved ejection fraction, interstitial lung disease, and pulmonaryveno-occlusive disease/pulmonary capillary hemangiomatosis. While agreeing there is a need for treatments that can cross World Health Organization PH classifications, the symposium clearly pointed out that improved phenotyping is still needed to better determine who will benefit from these therapies.

For a link to the full article, click here: https://www.atsjournals.org/doi/abs/10.1164/rccm.201710-2093PP?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed

Link to abstract online: https://www.ncbi.nlm.nih.gov/pubmed/?term=Challenges+in+Pulmonary+Hypertension%3A+Controversies+in+Treating+the+Tip+of+the+Iceberg

Share This Post